![Kathy Yi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathy Yi
Geschäftsführer bei
Affini-T Therapeutics, Inc.
Profil
Kathy Yi ist Mitglied des Vorstands von Sangamo Therapeutics UK Ltd. und Theseus Pharmaceuticals, Inc. In der Vergangenheit war Kathy Yi CFO, Secretary, Principal Accounting Officer & EVP bei Sangamo Therapeutics, Inc. und Chief Financial Officer bei Cerevel Therapeutics Holdings, Inc. sowie Director-Finance & Corporate Development bei Life Technologies Corp. und Head-Finance, Inhalation Technical R&D bei Novartis Pharmaceuticals Corp. Sie erwarb einen Bachelor-Abschluss an der University of California, Berkeley, und einen MBA an der Columbia Business School.
Aktive Positionen von Kathy Yi
| Unternehmen | Position | Beginn |
|---|---|---|
Sangamo Therapeutics UK Ltd.
 Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops transcription factors in the regulation of genes | Direktor/Vorstandsmitglied | 28.02.2017 |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Geschäftsführer | - |
Ehemalige bekannte Positionen von Kathy Yi
| Unternehmen | Position | Ende |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.02.2024 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Finanzdirektor/CFO | 20.09.2021 |
| SANGAMO THERAPEUTICS, INC. | Finanzdirektor/CFO | 07.06.2019 |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Finanzdirektor/CFO | 01.01.2014 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Ausbildung von Kathy Yi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Sangamo Therapeutics UK Ltd.
Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops transcription factors in the regulation of genes | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
